“Issues have been very China-specific to this point. I don’t see broader impact on the reverse merger market as a viable going-public alternative,” says Brett Goetschius, editor of The Reverse Merger Report.
While U.S. companies are expected to dominate the reverse-merger market, the industry is also setting its sight on other countries, particularly Brazil and Israel.
“We are busier than ever with non-China deals,” says David Feldman, a partner at law firm Richardson & Patel who advises reverse-merger transactions.
Yet, the industry’s optimism is up against a tough reality.
Regulators Step Up
Federal regulators have increased scrutiny of reverse mergers, and recently issued a warning about dangers of investing in foreign-based companies that have listed on U.S. exchanges by merging with public shell companies rather than going through the public offering process.
NASDAQ also is looking to toughen listing requirements for reverse mergers. The proposal is now under review by the U.S. Securities and Exchange Commission.
In addition, the Public Company Accounting Oversight Board, a Washington-based watchdog, warned that audits of reverse-merger companies that are based outside the U.S. may not always be conducted according to U.S. standards.
A slew of negative publicity curtailed opportunities for China-based deals, which were a sizeable share of the market over the past several years.
In 2010, 83 deals, or one-third of all reverse mergers came from China, making it the most active year on record for Chinese companies, according to the Reverse Merger Report. This year, there have been 27 deals so far.
The amount of money raised by Chinese reverse mergers is down to just $13 million, from $200 million last year.
Industry insiders insist reverse mergers remain a quicker and less-expensive way to go public. In fact, a number of well-known firms entered the market this way: Occidental Petroleum , Berkshire Hathaway , Turner Broadcasting, and Radio Shack , to name a few.
But critics say this “back door” route to the market lacks the regulatory rigors of the initial public offering process, and has been exploited by shady firms, particularly those from China.
This year alone, more than two dozen China-based companies, most of which are reverse mergers, announced auditor resignations or accounting problems. Last week, Nasdaq-listed China-Biotics said its auditor, BDO Limited, has resigned accusing management of accounting fraud. More than a dozen Chinese stocks, including China-Biotics , are currently halted on U.S. exchanges.
The SEC this spring suspended trading in Heli Electronics , China Changjiang Mining & New Energy , as well as Rino International because of irregularities in their financial statements. The agency also revoked securities registration of at least eight China-based companies.
Scandals put a damper on demand for Chinese deals. “I wouldn’t expect to see another Chinese IPO or reverse merger in the next 12 months or more,” says the Reverse Merger Report's Goetschius.
“Given the current valuations seen for Chinese companies, as well as waning investor enthusiasm for the sector, there appears to be little enthusiasm on the part of companies to explore the reverse merger route,” says John Borer, senior managing director at Rodman & Renshaw.